- Home
- PPT vs LFCR Comparison
PPT vs LFCR Comparison
Compare PPT & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPT
- LFCR
- Stock Information
- Founded
- PPT 1988
- LFCR 1986
- Country
- PPT United States
- LFCR United States
- Employees
- PPT N/A
- LFCR N/A
- Industry
- PPT Finance Companies
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- PPT Finance
- LFCR Health Care
- Exchange
- PPT Nasdaq
- LFCR Nasdaq
- Market Cap
- PPT 356.5M
- LFCR 308.8M
- IPO Year
- PPT N/A
- LFCR N/A
- Fundamental
- Price
- PPT $3.69
- LFCR $7.41
- Analyst Decision
- PPT
- LFCR Buy
- Analyst Count
- PPT 0
- LFCR 4
- Target Price
- PPT N/A
- LFCR $8.00
- AVG Volume (30 Days)
- PPT 156.1K
- LFCR 113.3K
- Earning Date
- PPT 01-01-0001
- LFCR 10-03-2025
- Dividend Yield
- PPT 8.84%
- LFCR N/A
- EPS Growth
- PPT N/A
- LFCR N/A
- EPS
- PPT N/A
- LFCR N/A
- Revenue
- PPT N/A
- LFCR $128,867,000.00
- Revenue This Year
- PPT N/A
- LFCR $4.78
- Revenue Next Year
- PPT N/A
- LFCR $12.02
- P/E Ratio
- PPT N/A
- LFCR N/A
- Revenue Growth
- PPT N/A
- LFCR 0.47
- 52 Week Low
- PPT $3.25
- LFCR $4.33
- 52 Week High
- PPT $3.72
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- PPT 54.02
- LFCR 47.27
- Support Level
- PPT $3.68
- LFCR $7.37
- Resistance Level
- PPT $3.72
- LFCR $8.69
- Average True Range (ATR)
- PPT 0.03
- LFCR 0.36
- MACD
- PPT 0.00
- LFCR 0.01
- Stochastic Oscillator
- PPT 61.11
- LFCR 17.83
About PPT Putnam Premier Income Trust
Putnam Premier Income Trust is a Massachusetts business trust operating as a non-diversified closed-end management investment company. The fund is currently operating as a diversified fund. Its investment objective is to seek high current income consistent with the preservation of capital by allocating its investments to the U.S. government sector.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.